Guggenheim Capital LLC Seagen Inc. Transaction History

Guggenheim Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $386,275 - $435,994	2,017 Added 2.82%	73,489 $15.6 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $1.78 Million - $1.96 Million	9,485 Added 15.3%	71,472 $13.8 Million
Q1 2023 May 10, 2023	SELL	$127.59 - $203.08 $872,843 - $1.39 Million	-6,841 Reduced 9.94%	61,987 $12.6 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $265,021 - $314,245	2,258 Added 3.39%	68,828 $8.85 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $177,338 - $236,124	-1,311 Reduced 1.93%	66,570 $9.11 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $487,795 - $803,936	-4,483 Reduced 6.2%	67,881 $12 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $1.07 Million - $1.41 Million	-8,952 Reduced 11.01%	72,364 $10.4 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $1 Million - $1.34 Million	7,026 Added 9.46%	81,316 $12.6 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $183,618 - $218,897	1,289 Added 1.77%	74,290 $12.6 Million
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $528,297 - $630,062	3,911 Added 5.66%	73,001 $11.5 Million
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $377,189 - $523,364	-2,743 Reduced 3.82%	69,090 $9.59 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $11.8 Million - $15.2 Million	71,833 New	71,833 $12.6 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.